Om

BiomX Inc. is a biotechnology company focused on developing phage-based therapies designed to target harmful bacteria linked to chronic diseases. Its current pipeline includes natural and engineered bacteriophage cocktails and personalized treatment approaches aimed at difficult-to-treat conditions such as cystic fibrosis, bronchiectasis, atopic dermatitis, and diabetic foot osteomyelitis. The company’s work centers on precision microbiome medicine, using bacteriophages to selectively attack pathogenic bacteria while preserving beneficial microbes. BiomX Inc. also advances product candidates intended for patients with persistent bacterial infections, supporting clinical-stage research and development in the broader phage therapy market. Based in Israel, BiomX Inc. serves the healthcare and biotechnology sectors through its focus on targeted anti-bacterial therapeutics and microbiome-directed innovation.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I TESSERA DEFENSE AND HOMELAND S MED ENDAVU: Køb Tessera Defense and Homeland S ($HLSQ) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Tessera Defense and Homeland S, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.